| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
4 companies
Freund John Gordon is a Director at TARA with holdings across 4 companies. Recent SEC Form 4 filings include 2 buys and 10 sells.
Estimated insider holdings value: $15.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2020 | SIBN Si-Bone, Inc. | Director, 10% Owner | Sell | 190,053 | $22.00 | $4,181,166.00 | -8.2% | |
| Sep 18, 2020 | STRO Sutro Biopharma, Inc. | Director | Sell | 400,000 | $12.00 | $4,800,000.00 | -41.7% | |
| Sep 11, 2020 | STRO Sutro Biopharma, Inc. | Director | Sell | 500,000 | $10.00 | $5,000,000.00 | -34.2% | |
| Aug 19, 2020 | STRO Sutro Biopharma, Inc. | Director | Sell | 500,000 | $8.72 | $4,360,000.00 | -25.5% | |
| Aug 26, 2019 | SIBN Si-Bone, Inc. | Director, 10% Owner | Sell | 152,424 | $18.40 | $2,805,180.81 | -3.8% | |
| Aug 23, 2019 | SIBN Si-Bone, Inc. | Director, 10% Owner | Sell | 47,576 | $20.15 | $958,469.62 | -0.3% | |
| Aug 12, 2019 | SIBN Si-Bone, Inc. | Director, 10% Owner | Sell | 400,000 | $18.25 | $7,300,000.00 | -9.0% | |
| Oct 19, 2018 | SIBN Si-Bone, Inc. | Director, 10% Owner | Buy | 325,000 | $15.00 | $4,875,000.00 | +7.9% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Director, 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +5.4% |